Antiasthmatic activity of the second-generation phosphodiesterase 4 (pde4) inhibitor sb 207499 (ariflo) in the guinea pig

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 3, 1998, Pages 988-995

  Underwood, David C ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CILOMILAST; HISTAMINE; HOUSE DUST ALLERGEN; LEUKOTRIENE D4; OVALBUMIN; PHOSPHODIESTERASE IV INHIBITOR; SALBUTAMOL; 3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; ANTIASTHMATIC AGENT; BRONCHODILATING AGENT; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; ENZYME INHIBITOR; PHOSPHODIESTERASE IV;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHODILATATION; BRONCHOSPASM; CONTROLLED STUDY; EOSINOPHILIA; GUINEA PIG; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TRACHEA; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; IN VITRO STUDY; MUSCLE CONTRACTION;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; ANTI-ASTHMATIC AGENTS; BRONCHIAL SPASM; BRONCHOCONSTRICTION; BRONCHODILATOR AGENTS; CYCLOHEXANECARBOXYLIC ACIDS; ENZYME INHIBITORS; GUINEA PIGS; HISTAMINE; LEUKOTRIENE D4; MUSCLE CONTRACTION; OVALBUMIN; TRACHEA;

EID: 0032246995     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Andersson P (1980) Antigen-induced bronchial anaphylaxis in actively sensitized guinea-pigs. Pattern of response in relation to immunization regimen. Allergy 35:65-71.
2. Beavo JA and Reifsnyder DH (1990) Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmac Sei 11:150-155.
3. Barnes PJ, Chung KF and Page CP (1988) Inflammatory mediators and asthma. Pharmacol Rev 40:49-84.
4. Barnette MS, Christensen SB, Underwood DC and Torphy TJ (1996) Phosphodiesterase 4: Biological underpinnings for the design of improved inhibitors. Environ Health Perspect 102:suppl 10, 79-84.
5. Barnette MS, Christensen SB, Essayan DM, Grous M, Prabhakar U, Rush JA, Kagey-Sobotka A and Torphy TJ (1998) SB 207499, a potent and selective second generation phosphodiesterase 4 inhibitor: In vitro anti-inflammatory actions. J Pharmacol Exp Ther 284:420-426.
6. Bertolino A, Crippa D, Di-Dio S, Fichte K, Musmeci G, Porro V, Rapisarda V, Sastre-Y-Hernandez M and Schratzer M (1988) Rolipram versus imipramine in inpatients with major, "minor" or atypical depressive disorder: A double-blind double-dummy study aimed at testing a novel therapeutic approach. Int Clin Psychopharmacol 3:245-253.
7. Bochnowicz S and Underwood DC (1995) Dose-dependent mediation of leukotriene D4-induced airway microvascular leakage and bronchoconstriction in the guineapig. Prostaglandins, Leukotrienes and Essential Fatty Acids 52:403-411.
8. Christensen SB, Guider .AM, Forster CJ, Gleason JG, Bender PB, Karpinski JM, De Wolf WE Jr, Barnette MS, Underwood DC, Griswold DE, Cieslinski LB, Burman M, Bochnowicz S, Osborn RR, Manning CD, Grous M, Hillegas LM, Bartus JO, Ryan MD, Eggleston DS, Haltiwanger RC and Torphy TJ (1998) 1,4Cyclohexane carboxylates: Potent and selective inhibitors of phosphodiesterase 4 for the treatment of asthma. J Med Chem 41:821-835.
9. Cohan VL, Showell HJ, Fisher DA, Pazoles CJ, Watson JW, Turner CR and Cheng JB (1996) In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633. J Pharmacol Exp Ther 278:1356-1361.
10. Dent G, Giembycz MA, Rabe KF and Barnes PJ (1991) Inhibition of eosinophilic cyclic nucleotide PDE activity and opsonized, zymosan-stimulated respiratory burst by "type IV-selective PDE inhibitors. Br J Pharmacol 103:1339-1346.
11. Dunn CJ, Elliot GA, Oostveen JA and Richards IM (1988) Development of a prolonged eosinophil-rich inflammatory leukocyte infiltration in the guinea pig asthmatic response to ovalbumin inhalation. Am Rev Respir Dis 137:541-547.
12. Giembycz MA and Raeburn D (1991) Putative substrates for cyclic nucleotidedependent protein kinases and the control of airway smooth muscle tone. J Auton Pharmacol 11:365-398.
13. Griswold DE, Webb EF, Badger AM, Gorycki PD, Lavandoski PA, Barnette MA, Grous M, Christensen S and Torphy TJ (1998) SB 207499 (Ariflo), a second generation phosphodiesterase 4 inhibitor, reduces tumor necrosis factor a and interleukin-4 production in vivo. J Pharmacol Exp Ther 287:705-711.
14. Harris AL, Connell MJ, Ferguson EW, Wallace AM, Gordon RJ, Pagani ED and Silver PJ (1989) Role of low-K, cyclic AMP phophodiesterase in trachéal relaxation and bronchodilation in the guinea pig. J Pharmacol Exp Ther 251:199-206.
15. Heaslip RJ and Evans E)Y (1995) Emetic, central nervous system, and pulmonary activities of rolipram in the dog. Eur J Pharmacol 286:281-290.
16. Hebenstreit GF, Feilerer K, Fichte K, Fischer G, Geyer N, Meya U, Sastre-YHernandez M, Schony W, Schratzer M, Soukop W et al. (1989) Rolipram in major depressive disorder: Results of a double-blind comparative study with imipramine. Phartnacopsychiatry 22:156-160.
17. Howell RE, Sickels BD and Woeppel SL (1993) Pulmonary antiallergic and bronchodilator effects of isozyme-selective phosphodiesterase inhibitors in guinea pigs. J Pharmacol Exp Ther 264:609-701.
18. Hughes B, Howat D, Lisle H, Holbrook M, James T, Gozzard N, Blease K, Hughes P, Kingaby R, Warrellow G, Alexander R, Head J, Boyd E, Eaton M, Perry M, Wales M, Smith B, Owens R, Catterall C, Lumb S, Russell A, Alien R, Merriman M, Bloxham D and Higgs G (1996) The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP840, a novel stereo-selective inhibitor of phosphodiesterase type 4. Br J Pharmacol 118:1183-1191.
19. Kaneko T, Alvarez R, Ueki IF and Nadel JA (1995) Elevated intracellular cyclic AMP inhibits chemotaxis in human eosinophils. Cell Signal 7:527-534.
20. O'Connolly M, Dierdorf D, Greb WH, Mayer M-ER and Wolf D (1988) Efficacy of denbufylline in patients with multi-infarct dementia. Drug Dev Res 14:195-199.
21. Patterson R and Kelly JF (1974) Animal models of the asthmatic state. Annu Rev Med 25:53-68.
22. Schwabe U, Miyaké M, Ohga Y and Daly JW (1976) 4-(3-Cyclopentyloxy-4methoxyphenyl)-2-pyrrolidone (ZK 62711): A potent inhibitor of adenosine cyclic 3',5'-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain. Mol Pharmacol 12:900-910.
23. Souness JE, Rao S (1997) Proposal for pharmacologically distinct conformers of PDE4 cyclic AMP phosphodiesterases. Cellular Signalling. 9(3-4):227-236,
24. Torphy TJ (1998) Phosphodiesterase isozymes: Molecular targets for novel antiasthma drugs. State-of-the-Art Review. Am J Resp Crit Care Med 157:351-370.
25. Torphy TJ, Barnette MS, Hay DWP and Underwood DC (1994) Phosphodiesterase IV inhibitors as therapy for eosinophil-induced lung injury in asthma. Environ Health Perspect 102:suppl 10, 79-84.
26. Torphy TJ, Christensen SB, Barnette MS, Burman M, Cieslinski LB and DeWolf WE Jr (1997) Molecular basis for an improved therapeutic index of SB 207499, a second generation phosphodiesterase 4 inhibitor. Eur Resp J 10:313s.
27. Torphy TJ and Hay DWP (1990) Biochemical regulation of airway smooth muscle tone: An overview, in Airway Smooth Muscle: Modulation of Receptors and Response, (Townley RG and Agrawal DK, eds) pp 39-68, CRC Press, Boca Raton.
28. Torphy TJ and Undem BJ (1991) Phosphodiesterase inhibitors: New opportunities for the treatment of asthma. Thorax 46:512-523.
29. Turner CR, Andresen CJ, Smith WB and Watson JW (1994) Effects of rolipram on responses to acute and chronic antigen exposure in monkeys. Am J Respir Crit Care Med 149:1153-1159.
30. Undem BJ, Buckner CK, Harley P and Graziano FM (1985) Smooth muscle contraction and release of histamine and slow-reacting substance of anaphylaxis in pulmonary tissues isolated from guinea pigs passively sensitized with IgGl or IgE antibodies. Am Rev Respir Dis 131:260-266.
31. Undem BJ, Pickett WC and Adams GK III (1987) Antigen-induced sulfidopeptide leukotriene release from the guinea pig superfused trachea. Eur J Pharmacol 142:31-37.
32. Underwood DC, Kotzer CJ, Bochnowicz S, Osborn RR, Luttmann MA, Hay DWP and Torphy TJ (1994) Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs. J Pharmacol Exp Ther 270:250-259.
33. Underwood DC, Matthews JK, Osborn RR, Novak LB, Bochnowicz S and Meunier L (1996a) Catecholamine and β-adrenoceptor influences on airway reactivity to antigen in guinea pigs. Int Arch Allergy Immunol 109:286-294.
34. Underwood DC, Osborn RR, Newsholme SJ, Torphy TJ and Hay DWP (1996b) Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig. Am J Resp Crit Care Med 154:850-857.
35. Underwood DC, Osborn RR, Novak LB, Matthews JK, Newsholme SJ, Undem BJ, Hand JM and Torphy TJ ( 1993) Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram. J Pharmacol Exp Ther 266:306-313.
36. Van Rossum JM (1963) Cumulative dose-response curves. II. Techniques for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn 143:299-330.